$CBIS "The GHC Summit will provide CBIS with a global platform to advance our relationship with the Dana-Farber Cancer Institute, as well as with other individuals and organizations. Given CBIS' Collaborative Research Agreement (CRA) with Dana-Farber, we are excited about the potential to jointly investigate and develop use of cannabinoids to treat various forms of cancers," stated Dr. Herman.

Information on this session is available at:
https://www.globalhealthcatalystsummit.org/agenda and http://www.huffingtonpost.com/felicia-m-knaul...63838.html.

http://www.marketwired.com/press-release/cann...210635.htm